HAMILTON THOMAS EDWARD purchased 17.7% of their position (100K shares) of LARIMAR THERAPEUTICS, INC. on the open market
Open‑market purchase worth $500.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/2/2026ACC: 0001193125-26-085515
Director
Since May 2020
+100K
Net shares
Net buyer
$500.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$5.00
Trade value
$500K
% of position
17.7%
2/27/2026
564.80K→664.80K
Total
Net shares
+100K
Net value
$500K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | P · Purchase | +100K | $5.00 | $500K | 17.7% | 564.80K | 664.80K |
| Total | +100K | $500K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned159.43K
Total
159.43K indirect159.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 159.43K | Indirect |
| Total | 159.43K | 159.43K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported